|
Market Closed -
Hong Kong S.E.
01:38:36 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.040 HKD | -3.70% |
|
-5.45% | +30.00% |
| 03/08 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 66Cr 77Cr 9.8Cr 8.46Cr 7.95Cr 7.23Cr 14Cr 936.89Cr 14Cr 93Cr 36Cr 469.16Cr 37Cr 36Cr 1.56TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 88Cr 102.72Cr 13Cr 11Cr 11Cr 9.66Cr 18Cr 1.25TCr 18Cr 124.47Cr 49Cr 626.77Cr 49Cr 48Cr 2.08TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.70% | ||
| 1 week | -5.45% | ||
| Current month | +2.97% | ||
| 1 month | +2.97% | ||
| 6 months | +11.83% | ||
| Current year | +30.00% |
| 1 week | 0.98 |  | 1.08 |
| 1 month | 0.98 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.32 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.70% | -5.45% | +192.96% | -28.28% | 9.8Cr | |
| -0.10% | -0.77% | +17.58% | +70.16% | 4.84TCr | |
| -3.26% | -5.31% | +52.47% | +114.13% | 3.97TCr | |
| -0.60% | -0.94% | -7.29% | +17.35% | 1.23TCr | |
| -2.75% | +1.88% | +14.81% | +76.92% | 1.18TCr | |
| -0.58% | -0.77% | +29.90% | +135.00% | 906.17Cr | |
| +1.56% | +5.52% | +23.69% | +41.38% | 756.57Cr | |
| +0.52% | +2.08% | +42.23% | -13.42% | 717.59Cr | |
| -0.07% | +1.72% | +13.39% | +190.65% | 684.21Cr | |
| -2.51% | -3.14% | -30.53% | +23.54% | 576.86Cr | |
| Average | -1.15% | +1.04% | +34.92% | +62.74% | 1.49TCr | |
| Weighted average by Cap. | -1.21% | +1.00% | +24.94% | +80.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.83Cr 4.18Cr 3.92Cr 3.57Cr 6.71Cr 462.23Cr 6.82Cr 46Cr 18Cr 231.47Cr 18Cr 18Cr 769.21Cr | 27Cr 32Cr 4.05Cr 3.5Cr 3.29Cr 2.99Cr 5.62Cr 387.57Cr 5.72Cr 39Cr 15Cr 194.08Cr 15Cr 15Cr 644.96Cr |
| Net income | -19Cr -22Cr -2.8Cr -2.42Cr -2.27Cr -2.07Cr -3.88Cr -267.65Cr -3.95Cr -27Cr -10Cr -134.03Cr -11Cr -10Cr -445.4Cr | -1.18Cr -1.37Cr -17.47L -15.09L -14.18L -12.9L -24.25L -17Cr -24.65L -1.66Cr -64.96L -8.37Cr -65.6L -64.17L -28Cr |
| Net Debt | 37Cr 43Cr 5.45Cr 4.7Cr 4.42Cr 4.02Cr 7.56Cr 520.66Cr 7.68Cr 52Cr 20Cr 260.73Cr 20Cr 20Cr 866.45Cr | 22Cr 26Cr 3.29Cr 2.84Cr 2.67Cr 2.43Cr 4.57Cr 314.73Cr 4.64Cr 31Cr 12Cr 157.61Cr 12Cr 12Cr 523.75Cr |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | HK$1.040 | -3.70% | 66,000 |
| 13/26/13 | HK$1.080 | 0.00% | 6,000 |
| 12/26/12 | HK$1.080 | +1.89% | 60,000 |
| 11/26/11 | HK$1.060 | 0.00% | 4,000 |
| 10/26/10 | HK$1.060 | -3.64% | 77,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
